Table 2 Change in risk marker values from baseline to 3-months
Placebo (N = 35) Mean (SD) | Omega-3 (N = 27) Mean (SD) | |
|---|---|---|
Pulse Wave Velocity (cm/s) | −33 (306) | −97 (182) |
Total cholesterol (mg/dL) | −6.6 (30.4) | −0.8 (18.1) |
Triglycerides (mg/dL) | −30.0 (58.1) | −17.6 (45.6) |
HDL-C (mg/dL) | 0.2 (8.5) | 2.9 (14.6) |
LDL-C (mg/dL) | −2.8 (28.6) | 0.7 (18.3) |
Hemoglobin A1c (%) | −0.13 (0.94) | 0.06 (0.44) |
Glucose (mg/dL) | −13.1 (44.0) | 0.6 (23.0) |
hsCRP (mg/L) | 0.9 (4.4) | −0.9 (3.1) |
Adiponectin (ug/mL) | 0.3 (3.4) | −0.4 (2.4) |
LpPLA2 mass (ng/mL) | −6.1 (31.7) | −18.1 (41.1) |